FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Lehrstuhl für Innere Medizin III
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Medicine 3 – Rheumatology and Immunology
Overview
Publications
(1,515)
Research Grants
(7)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52 (2021)
Behrens F, Leage SL, Sapin C, El Baou C, De La Torre I, Meszaros G, Schett G, et al.
Journal article
Enasidenib in IDH-2 mutant AML patients with relapse after allogeneic stem cell transplantation (2021)
Vasova I, Spörl S, Guggenberger V, Berisha M, Rech D, Behzad A, Brandt A, et al.
Conference contribution
Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients (2021)
Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, et al.
Conference contribution
Clusters of Psoriatic Arthritis Patients at Baseline Based on Different Ultrasound Detected Synovitis: Exploratory Analysis from a Phase III Study (2021)
D'Agostino MA, Schett G, Gaillez C, Conaghan P, Naredo E, Carron P, Burgos-Vargas R, et al.
Conference contribution
Guselkumab (TREMFYA (R)) Maintains Resolution of Dactylitis and Enthesitis in Patients with Active Psoriatic Arthritis: Results Through 2 Years from a Phase 3 Study (2021)
Rahman P, Mcinnes I, Deodhar A, Schett G, Mease P, Shawi M, Cua D, et al.
Conference contribution
Ultrasound Demonstrates Continued Improvement in Psoriatic Arthritis Synovitis and Enthesitis with Secukinumab: 52-week Results from a Phase III Study (2021)
D'Agostino MA, Schett G, Gaillez C, Guerrero C, Hanova P, Cazenave T, Stoenoiu MS, et al.
Conference contribution
Bimekizumab in Patients with Psoriatic Arthritis: 3-Year Results for Overall and Tumor Necrosis Factor Inhibitor (TNFi)-Naive Populations from a Phase 2b Open-Label Extension Study (2021)
Mease P, Deodhar A, Merola J, Mcinnes I, Assudani D, Bajracharya R, Coarse J, et al.
Conference contribution
Secukinumab Treatment Provides Sustained Resolution of Enthesitis at Individual Joints Through 52 Weeks in a Phase 3b, Double-Blind, Randomized, Active-Controlled Study (2021)
Kaeley G, Schett G, Conaghan P, Mcgonagle D, Behrens F, Goupille P, Gaillez C, et al.
Conference contribution
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory Disease (2021)
Haberman R, Herati R, Simon D, Samanovic M, Tuen M, Blank R, Koralov S, et al.
Conference contribution
Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging (2021)
Schmidkonz C, Rauber S, Atzinger A, Götz TI, Soare A, Cordes M, Prante O, et al.
Journal article
‹
1
...
39
40
41
42
43
...
145
›